Idiopathic mesenteric phlebosclerosis associated with long-term oral intake of geniposide

doi:10.3748/wjg.v27.i22.3097

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 27, Issue 22

This Article

(237)

(266)

(0)

(10)

(9013)

(23)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Retrospective Study

World J Gastroenterol. Jun 14, 2021; 27(22): 3097-3108
Published online Jun 14, 2021. doi: 10.3748/wjg.v27.i22.3097

Full Size Figure Download Figure

Figure 4 Dispersion diagram and best fitting line for the drinking index vs the disease computed tomography score. Patients two, seven, and eight had histories of diabetes, chronic nephritis, or prostate cancer are shown by red dots. CT: Computed tomography.

Citation: Wen Y, Chen YW, Meng AH, Zhao M, Fang SH, Ma YQ. Idiopathic mesenteric phlebosclerosis associated with long-term oral intake of geniposide. World J Gastroenterol 2021; 27(22): 3097-3108
URL: https://www.wjgnet.com/1007-9327/full/v27/i22/3097.htm
DOI: https://dx.doi.org/10.3748/wjg.v27.i22.3097

Wen Y, Chen YW, Meng AH, Zhao M, Fang SH, Ma YQ. Idiopathic mesenteric phlebosclerosis associated with long-term oral intake of geniposide. World J Gastroenterol 2021; 27(22): 3097-3108 [PMID: 34168411 DOI: 10.3748/wjg.v27.i22.3097]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.